{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:33:38Z","timestamp":1787009618853,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:00:00Z","timestamp":1589673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ministerio de Econom\u00eda y Competitividad - Instituto de Salud Carlos III","award":["FIS PI16\/01189"],"award-info":[{"award-number":["FIS PI16\/01189"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad - Instituto de Salud Carlos III","award":["FIS PI13\/00084"],"award-info":[{"award-number":["FIS PI13\/00084"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad - Instituto de Salud Carlos III","award":["RD16\/0012\/0012"],"award-info":[{"award-number":["RD16\/0012\/0012"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad - Instituto de Salud Carlos III","award":["RD12\/0009\/0012"],"award-info":[{"award-number":["RD12\/0009\/0012"]}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The protagonism of regulatory B cells seems to vary along the course of the disease in murine models of inflammatory conditions. Decreased numbers of circulating regulatory CD19+CD24hiCD38hi transitional (cTr) B cells have been described in patients with long-standing RA, thus our objective was to examine the frequency and evolution of cTr B cells in the peripheral blood of early RA (ERA) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Freshly isolated peripheral blood mononuclear cells from 48 steroid- and DMARD-na\u00efve ERA patients with a disease duration of &amp;lt;24\u2009weeks and 48 healthy controls (HCs) were examined by flow cytometry. Co-cultures of isolated memory B cells were established with autologous T cells in the absence or presence of Tr B cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As compared with HCs, ERA patients demonstrated an increased frequency of cTr B cells. cTr B cells of ERA patients and HCs displayed an anti-inflammatory cytokine profile and were able to downregulate T cell IFN-\u03b3 and IL-21 production, together with ACPA secretion in autologous B\/T cell co-cultures. Basal frequencies of cTr B cells above the median value observed in HCs were associated with a good EULAR response to MTX at 12\u2009months [relative risk 2.91 (95% CI 1.37, 6.47)]. A significant reduction of cTr B cells was observed 12\u2009months after initiating MTX, when the cTr B cell frequency was no longer elevated but decreased, and this was independent of the degree of clinical response or the intake of prednisone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An increased frequency of regulatory cTr B cells is apparent in untreated ERA and the baseline cTr B cell frequency is associated with the clinical response to MTX at 12\u2009months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa186","type":"journal-article","created":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T15:07:08Z","timestamp":1585494428000},"page":"3081-3091","source":"Crossref","is-referenced-by-count":20,"title":["Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis"],"prefix":"10.1093","volume":"59","author":[{"given":"Paula","family":"Fortea-Gordo","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Villalba","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nu\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Santos-B\u00f3rnez","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Peiteado","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Monjo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Puig-Kr\u00f6ger","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Oncolog\u00eda, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"S\u00e1nchez-Mateos","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Oncolog\u00eda, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Mart\u00edn-Mola","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Balsa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Eugenia","family":"Miranda-Car\u00fas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario La Paz-IdiPaz"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,17]]},"reference":[{"key":"2020092423554160600_keaa186-B1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2020092423554160600_keaa186-B2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol"},{"key":"2020092423554160600_keaa186-B3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"2020092423554160600_keaa186-B4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10\u2013producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"2020092423554160600_keaa186-B5","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"2020092423554160600_keaa186-B6","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.4049\/jimmunol.0902391","article-title":"Protective and pathogenic roles for B cells during systemic autoimmunity in NZB\/W F1 mice","volume":"184","author":"Haas","year":"2010","journal-title":"J Immunol"},{"key":"2020092423554160600_keaa186-B7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","article-title":"Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis","volume":"185","author":"Matsushita","year":"2010","journal-title":"J Immunol"},{"key":"2020092423554160600_keaa186-B8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"2020092423554160600_keaa186-B9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"2020092423554160600_keaa186-B10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.1600218","article-title":"Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients","volume":"198","author":"Bank\u00f3","year":"2017","journal-title":"J Immunol"},{"key":"2020092423554160600_keaa186-B11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fimmu.2018.00961","article-title":"IL-10 producing B cells ability to induce regulatory T cells is maintained in rheumatoid arthritis","volume":"9","author":"Mielle","year":"2018","journal-title":"Front Immunol"},{"key":"2020092423554160600_keaa186-B12","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J. Immunol"},{"key":"2020092423554160600_keaa186-B13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"2020092423554160600_keaa186-B14","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting Th1 and Th17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"2020092423554160600_keaa186-B15","doi-asserted-by":"crossref","first-page":"20044","DOI":"10.1038\/srep20044","article-title":"IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses","volume":"6","author":"Nova-Lamperti","year":"2016","journal-title":"Sci Rep"},{"key":"2020092423554160600_keaa186-B16","doi-asserted-by":"crossref","first-page":"e0180726","DOI":"10.1371\/journal.pone.0180726","article-title":"Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with ankylosing spondylitis (AS) na\u00efve for biological agents","volume":"12","author":"Bautista-Caro","year":"2017","journal-title":"PLoS One"},{"key":"2020092423554160600_keaa186-B17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020092423554160600_keaa186-B18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2020092423554160600_keaa186-B19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory functioninautoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"2020092423554160600_keaa186-B20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int Immunol"},{"key":"2020092423554160600_keaa186-B21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2006-10-053793","article-title":"Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse","volume":"110","author":"Reichardt","year":"2007","journal-title":"Blood"},{"key":"2020092423554160600_keaa186-B22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10067-013-2359-3","article-title":"Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis","volume":"33","author":"Ma","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2020092423554160600_keaa186-B23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020092423554160600_keaa186-B24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/kez169","article-title":"Two populations of circulating PD-1hiCD4 T cells with distinct\u00a0B cell helping capacity are elevated in early rheumatoid arthritis","volume":"58","author":"Fortea-Gordo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2020092423554160600_keaa186-B25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-202893","article-title":"Circulating plasmablasts\/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis","volume":"72","author":"Kerkman","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020092423554160600_keaa186-B26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"2020092423554160600_keaa186-B27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s13075-014-0500-6","article-title":"Constitutively altered frequencies of circulating follicular helper T cell counterparts and their subsets in rheumatoid arthritis","volume":"16","author":"Arroyo-Villa","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2020092423554160600_keaa186-B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","article-title":"Peripheral development of B cells in mouse and man","volume":"197","author":"Carsetti","year":"2004","journal-title":"Immunol Rev"},{"key":"2020092423554160600_keaa186-B29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2020092423554160600_keaa186-B30","first-page":"S93","article-title":"The Disease Activity Score and the EULAR response criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2020092423554160600_keaa186-B31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"2020092423554160600_keaa186-B32","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1136\/annrheumdis-2013-203566","article-title":"An immunological biomarker to predict MTX response in early RA","volume":"73","author":"Ponchel","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020092423554160600_keaa186-B33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-017-1244-x","article-title":"Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis","volume":"19","author":"Salomon","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2020092423554160600_keaa186-B34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/rheumatology\/key263","article-title":"Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis","volume":"58","author":"Dekkers","year":"2019","journal-title":"Rheumatology (Oxford"},{"key":"2020092423554160600_keaa186-B35","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/annrheumdis-2011-200736","article-title":"Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)","volume":"71","author":"Wevers-de Boer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2020092423554160600_keaa186-B36","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.3892\/mmr.2015.3927","article-title":"Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status","volume":"12","author":"Zheng","year":"2015","journal-title":"Mol Med Rep"},{"key":"2020092423554160600_keaa186-B37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.2010.137703","article-title":"Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial","volume":"70","author":"Tak","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092423554160600_keaa186-B38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2020092423554160600_keaa186-B39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/keq029","article-title":"Alterations on peripheral blood B-cell subpopulations in very early arthritis patients","volume":"49","author":"Moura","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2020092423554160600_keaa186-B40","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice","volume":"182","author":"Blair","year":"2009","journal-title":"J Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3081\/33790211\/keaa186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3081\/33790211\/keaa186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T23:59:26Z","timestamp":1600991966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/3081\/5838307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,17]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,5,17]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa186","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,5,17]]}}}